FDA Approves First Nonhormonal Drug, Veozah, to Ease Menopause Hot Flashes

MONDAY, May 15, 2023 -- The U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes.
The new pill, called Veozah (fezolinetant), is a neurokinin 3 (NK3) receptor antagonist. "It...